Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Autism Spectrum Disorder

3,4-methylenedioxyamphetamine has been researched along with Autism Spectrum Disorder in 3 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Smith, R1
Netto, J1
Gribble, NC1
Falkmer, M1
Dugdale, AS1
Thompson, AR1
Leedham, A1
Beail, N1
Freeth, M1
Cohen, SR1
Miguel, J1

Other Studies

3 other studies available for 3,4-methylenedioxyamphetamine and Autism Spectrum Disorder

ArticleYear
'At the End of the Day, It's Love': An Exploration of Relationships in Neurodiverse Couples.
    Journal of autism and developmental disorders, 2021, Volume: 51, Issue:9

    Topics: Autism Spectrum Disorder; Humans; Interpersonal Relations; Love; Sexual Behavior; Sexual Partners

2021
Intense connection and love: The experiences of autistic mothers.
    Autism : the international journal of research and practice, 2021, Volume: 25, Issue:7

    Topics: Adult; Autism Spectrum Disorder; Autistic Disorder; Child; Emotions; Female; Humans; Love; Mothers;

2021
Amor and Social Stigma: ASD Beliefs Among Immigrant Mexican Parents.
    Journal of autism and developmental disorders, 2018, Volume: 48, Issue:6

    Topics: Adult; Autism Spectrum Disorder; Child; Culture; Emigrants and Immigrants; Female; Focus Groups; Hum

2018